Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
193
datasets available to search
ShareScore release 0.9.0
Dataset results
193 results for “CD20”
A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01609023. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01397591. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia
ClinicalTrials.gov study NCT02933320. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL
ClinicalTrials.gov study NCT00089284. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas
ClinicalTrials.gov study NCT00493454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II
ClinicalTrials.gov study NCT00291928. IPD Sharing: Not stated. Countries: 0. Publications: 2.
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
ClinicalTrials.gov study NCT05100862. IPD Sharing: YES. Countries: 28. Publications: 0.
Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A
ClinicalTrials.gov study NCT02406092. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies
ClinicalTrials.gov study NCT02483000. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403
ClinicalTrials.gov study NCT00655824. IPD Sharing: Not stated. Countries: 5. Publications: 0.
T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin Lymphoma
ClinicalTrials.gov study NCT04160195. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety of HMA-CD20 in Patients With HFrEF
ClinicalTrials.gov study NCT03332888. IPD Sharing: NO. Countries: 0. Publications: 1.
A Study to Evaluate Safety, Tolerability, PK and PD of HLX01 in Patients With CD20-positive B-cell Lymphomas
ClinicalTrials.gov study NCT03218072. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders
ClinicalTrials.gov study NCT00071396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pharmacokinetic and Pharmacodynamic Study Comparing HLX01 And Rituximab in Patients With CD20-Positive, B-cell Lymphoma
ClinicalTrials.gov study NCT02584920. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO)
ClinicalTrials.gov study NCT02391545. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Orelabrutinib in Combination With R2 Regimen for R/R CD20+ B-cell Lymphoma
ClinicalTrials.gov study NCT05014100. IPD Sharing: NO. Countries: 0. Publications: 4.
Effect of anti-CD20 treatment on the composition and gene expression of meningeal ectopic lymphoid tissue and CSFin a spontaneous EAE model, using single cell gene expression .
GEO Series GSE181506. Mus musculus. 18 samples. Type: Expression profiling by high throughput sequencing.
Monoclonal antibodies binding to different epitopes of CD20 differentially sensitizes DLBCL to different classes of chemotherapy
GEO Series GSE228687. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
RNA-seq analysis of paired Non-Hodgkin's lymphoma (NHL) tumor samples at pretreatment and after mosunetuzumab relapse coinciding with the loss of CD20 protein
GEO Series GSE243919. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.